Cellino | LinkedIn (original) (raw)

Biotechnology Research

Cambridge, Massachusetts 16,365 followers

Your Cells, Your Cure™

View all 85 employees

About us

Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.

Industry

Biotechnology Research

Company size

51-200 employees

Headquarters

Cambridge, Massachusetts

Type

Privately Held

Founded

2017

Locations

Employees at Cellino

Updates

🔬 Join the conversation with Willie T. Reaves, our Head of Public Engagement, at the 2024 Precision Health Summit in #NYC on October 9-10, 2024. Willie will moderate the panel "Ensuring Equitable Access to Precision Regenerative Medicine" from 3:15 PM - 4:00 PM EDT on October 9. We’re honored to welcome Peter Marks, MD, PhD, from the Center for Biologics Evaluation and Research at the FDA, as a featured panelist, joining Parastoo Khoshakhlagh, Ph.D., Co-Founder and CEO of GC Therapeutics, and Brigitte Arduini, Principal Investigator at the Regenerative Research Foundation/Neural Stem Cell Institute. Panelists will explore the challenges and potentials of leveraging #AI, #bigdata, and #genomics to deliver personalized health and treatment solutions. 🎤 Session: Ensuring Equitable Access to Precision Regenerative Medicine 🗓️ Date: October 9, 2024 ⏰ Session Time: 3:15 PM - 4:00 PM EDTMatthias Wagner, our CTO & Co-Founder, will also be in attendance and is excited to engage and connect with you at the summit! 👉 Register to join us in-person or virtually: https://bit.ly/3XylrLl 1BusinessWorld #Biotech #RegenerativeMedicine #PersonalizedMedicine #HealthcareInnovation #AIinHealthcare #YourCellsYourCure #CellinoBio #Biomanufacturing
🚀 Less than a month to go until #CGMesa24! Our CEO & Co-Founder, Nabiha Saklayen, and Co-Founder & Chief Product Officer, Marinna Madrid, PhD, will be speaking at the 2024 Meeting on the Mesa, October 7-9 in #Phoenix, Arizona! 🗓 Mark your calendars and join us on October 8: 🔹11:45 AM - 12:00 PM MDT: Nabiha will deliver Cellino’s company presentation in FLW Ballroom G. 🔹 11:00 - 11:40 AM MDT: Marinna will speak on the panel "Next Generation CGT Process Development and Manufacturing - Improving Efficiencies and Reducing Cost of Goods," including Philippe Cronet of WACKER, Kenneth Harris of OmniaBio, and Rick M. of Affinia Therapeutics in FLW Ballroom E. 🌟 Interested in learning more about Cellino’s scalable #biomanufacturing tech stack during the conference? Be sure to request a meeting with our team in advance through the partnering portal: meetingonthemesa.comWe look forward to connecting and seeing you soon! 🤝Alliance for Regenerative Medicine #AllianceRM #Biotech #AI #RegenMed #MachineLearning #Collaboration #Innovation #Therapeutics #PersonalizedMedicine #YourCellsYourCure #CellinoBio
16,365 followers
1w Edited
🌟 Biotech Week Boston is here! We’re thrilled that Marinna Madrid, PhD, our Co-Founder & Chief Product Officer, will be speaking at the upcoming BioProcess International conference (#BPIconf), September 24-26, 2024. 🗓️ Mark your calendars and join us for Marinna’s upcoming sessions! 🔹 Tuesday, September 24, 11:45 AM - 12:15 PM EDT: Marinna will present on "An AI- and Laser-based Biomanufacturing Platform to Scale Production of Personalized Regenerative Cell Therapies." Join us to explore how Cellino’s innovative platform uses an AI-driven optical bioprocess to enhance the scalability and consistency of autologous iPSC-derived therapy #biomanufacturing, addressing the challenges of current manual processes. 🔹 Thursday, September 26, 2:00 PM - 3:00 PM EDT: Marinna will join an exceptional panel of #biotech leaders to discuss "Adaptability of AI/ML for the BioPharma Industry," including William Whitford, Independent Consultant, and Christoph Herwig, Senior Scientific Advisor at Körber Pharma Austria GmbH. Moderator Amish Patel, Ph.D., SVP, Technical Operations at Calidi Biotherapeutics, will lead the discussion of how AI/ML is transforming biopharma, covering topics including AI/ML implementation strategies, cost reduction, accelerated timelines, and digitalization in manufacturing. 👉 See more details and the full agenda here: https://lnkd.in/gDsiYiNn #BiotechWeekBoston #Biotech #BPI #BioProcess #Innovation #AI #MachineLearning #PersonalizedMedicine #RegenMed #YourCellsYourCure #CellinoBio